WHO launches new global influenza strategy    
submitted by kickingbird at Mar, 12, 2019 from WHO
WHO released a Global Influenza Strategy for 2019-2030 aimed at protecting people in all countries from the threat of influenza. The goal of the strategy is to prevent seasonal influenza, control the spread ...

OIE: Highly pathogenic influenza A viruses (Infection with H5) (non-poultry including wild birds) (2017-), Russia    
submitted by kickingbird at 6 days ago from OIE
Summary Report type: immediate notification Started: 27 Sep 2021 Confirmed: 4 Oct 2021 Reported: 6 Oct 2021 Reason for notification: recurrence Last occurrence: 25 Jan 2021 Causal agent: highly pathogenic ...

OIE: Highly pathogenic avian influenza (H5), Kazakhstan    
submitted by kickingbird at 7 days ago from OIE
Summary Report type: immediate notification Started: 22 Sep 2021 Confirmed: 24 Sep 2021 Reported: 6 Oct 2021 Reason for notification: 1st occurrence in a zone or a compartment Causal agent: highly pathogenic ...

China: CHP closely monitors two human cases of avian influenza A(H5N6) in Mainland    
submitted by kickingbird at Sep, 30, 2021 from The Government of HongKong S.A.R Press Releases
The Centre for Health Protection (CHP) of the Department of Health of HongKong S.A.R is (September 30) closely monitoring two human cases of avian influenza A(H5N6) in the Mainland, and again urged the ...

China: CHP closely monitors fatal human case of avian influenza A(H5N6) in Mainland    
submitted by kickingbird at Sep, 29, 2021 from The Government of HongKong S.A.R Press Releases
The Centre for Health Protection (CHP) of the Department of Health of HongKong S.A.R is (September 29) closely monitoring a human case of avian influenza A(H5N6) in the Mainland, and again urged the public ...

Alqazlan N, Emam M, Nagy é, Bridle B, Sargolzaei M. Transcriptomics of chicken cecal tonsils and intestine after infection with low pathogenic avian influenza virus H9N2. Sci Rep. 2021 Oct 14;11(1):20462.  Abstract  
submitted by kickingbird at 2 days ago from Sci Rep. 2021 Oct 14;11(1):20462
Influenza viruses cause severe respiratory infections in humans and birds, triggering global health concerns and economic burden. Influenza infection is a dynamic process involving complex biological host ...

Kombiah S, Kumar M, Murugkar HV, Nagarajan S, Tosh. Role of expression of host cytokines in the pathogenesis of H9N2-PB2 reassortant and non-reassortant H5N1 avian influenza viruses isolated from crows in BALB/c mice. Microb Pathog. 2021 Oct 11:105239.  Abstract  
submitted by kickingbird at 2 days ago from Microb Pathog. 2021 Oct 11:105239
The present experiment was conducted to study the role of cytokine, chemokine and TLRs responses of H9N2-PB2 reassortant H5N1 viruses as compared to non-reassortant H5N1 viruses isolated from crows in ...

Wang F, Wan Z, Wu J, Wang Y, Fu H, Shao H, Qian K,. A Cross-Reactive Monoclonal Antibody Against Neuraminidases of Both H9N2 and H3N2 Influenza Viruses Shows Protection in Mice Challenging Models. Front Microbiol. 2021 Sep 27;12:730449.  Abstract  
submitted by kickingbird at 2 days ago from Front Microbiol. 2021 Sep 27;12:730449
Neuraminidases (NAs) of H9N2 avian influenza virus (AIV) and H3N2 human seasonal influenza virus (HSIV) share similar antigenic structures. However, there are few reports on epitopes shared by these two ...

Vien Chinh C, Phu Quoc V, Huynh Tan L, Nguyen Van. Persistence of vaccine-induced antibody to A/H5N1 influenza after 30 and 36 months of vaccination. Epidemiol Health. 2021 Oct 6:e2021076.  Abstract  
submitted by kickingbird at 2 days ago from Epidemiol Health. 2021 Oct 6:e2021076
Objectives: An A/H5N1 vaccine named IVACFLU-A/ H5N1 was accepted to use in Vietnam, however, antibody persistence after vaccination has not been well characterized yet. We examined the persistence of antibodies ...

Shibuya M, Tamiya S, Kawai A, Hirai T, Cragg MS, Y. Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza. iScience. 2021 Sep 15;24(10):103131.  Abstract  
submitted by kickingbird at 6 days ago from iScience. 2021 Sep 15;24(10):103131
Current influenza vaccines do not typically confer cross-protection against antigenically mismatched strains. To develop vaccines conferring broader cross-protection, recent evidence indicates the crucial ...